CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Irinotecan/capecitabine versus cisplatin/capecitabine in advanced adenocarcinoma of the stomach or gastroesophageal junction: Interimsanalysis of a randomized German AIO phase II study
DOI 10.1055/s-2006-950875
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Moehler, S Kanzler, M Geissler, J Raedle, M Ebert, H Scherübl, T Flieger, T Seufferlein, PR Galle, T Hoehler
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe09/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Irinotecan in combination with 5-FU is highly effective in advanced or metastatic gastric cancer. In addition, capecitabine seems to be at least as effective as 5-FU, with its advantage of oral administration. Thus, we compared efficacy and toxicity of the combinations of irinotecan/capecitabine versus cisplatin/capecitabine. Methods: Patients (pts) with previously untreated locally advanced or metastatic aden…
Zitieren
Zitierempfehlung
M Moehler, S Kanzler, M Geissler, J Raedle, M Ebert, H Scherübl, T Flieger, T Seufferlein, PR Galle, T Hoehler (2006) Irinotecan/capecitabine versus cisplatin/capecitabine in advanced adenocarcinoma of the stomach or gastroesophageal junction: Interimsanalysis of a randomized German AIO phase II study. Zeitschrift für Gastroenterologie (09). https://doi.org/10.1055/s-2006-950875
Mit CareLit weiterarbeiten